3.9 Article

Correlation Between Epithelial Ingrowth and Basement Membrane Remodeling in Human Corneas After Laser-Assisted In Situ Keratomileusis

Journal

ARCHIVES OF OPHTHALMOLOGY
Volume 128, Issue 4, Pages 426-436

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archophthalmol.2010.23

Keywords

-

Categories

Funding

  1. National Eye Institute [R01-EY012651, P30-EY014801, R01-EY00933]
  2. Research to Prevent Blindness
  3. Walter G. Ross Foundation

Ask authors/readers for more resources

Objective: To further investigate the hypothesis that epithelial ingrowth in human corneas after laser-assisted in situ keratomileusis (LASIK) correlates with basement membrane remodeling, as suggested by the presence of matrix metalloproteinase 9 around epithelial cells in the lamellar scar. Methods: Immunohistochemical analysis and transmission electron microscopy were applied to human postmortem corneas with post-LASIK epithelial ingrowth. Results: Epithelial ingrowth into the flap margin was observed in 8 of 18 corneas (44%). Matrix metalloproteinase 9 immunolocalized around ingrown epithelium in 6 of these 8 corneas (75%). There was a positive correlation between the presence of matrix metalloproteinase 9 at the wound margin and discontinuities in the basement membrane, as determined by laminin and beta(4) integrin immunofluorescence. Transforming growth factor beta 2 was present into the stroma of some corneas with epithelial ingrowth and interrupted basement membrane, suggesting some degree of epithelial-stromal interaction. Transmission electron microscopy confirmed large areas of remodeled basement membrane along ingrown epithelial cells. Conclusions: The neo-basement membrane components underlying the ingrown cells in human corneas with epithelial ingrowth after LASIK appear to be partially disassembled. Epithelial-stromal interaction over time may be related to prolonged wound healing remodeling, which calls into question the stability of the flap.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

Evaluation of the nurse triage at the ophtalmology emergency department of Pierre-Paul-Riquet Hospital

A. Renouvin-Benat, P. Sabatier, F. Varenne, V Pagot-Mathis, P. Fournie, F. Malecaze, A. Gallini, V Soler

JOURNAL FRANCAIS D OPHTALMOLOGIE (2018)

Article Ophthalmology

Transepithelial photorefractive intrastromal corneal crosslinking versus photorefractive keratectomy in low myopia

Safa El Hout, Myriam Cassagne, Thomas Sales de Gauzy, Stephane Galiacy, Francois Malecaze, Pierre Fournie

JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2019)

Review Ophthalmology

Clinical Characteristics and Outcomes of Ocular Cicatricial Pemphigoid: A Cohort Study and Literature Review

Felix Fremont, Cyrielle Pelissier-Suarez, Pierre Fournie, Marie Porterie, Anais Thevenin, Leonardo Astudillo, Kim Paricaud, Vincent Gualino, Vincent Soler, Gregory Pugnet

CORNEA (2019)

Article Dermatology

Incidence and risk factors for dupilumab associated ocular adverse events: a real-life prospective study

A. T. Touhouche, M. Cassagne, E. Berard, F. Giordano-Labadie, A. Didier, P. Fournie, C. Paul, M. Tauber

Summary: This study investigated the incidence and nature of ocular adverse events induced by dupilumab in AD patients. Most patients developed or worsened dry eye disease, with predisposing factors including eyelid eczema and high IgE serum levels. Further research is needed to better understand the pathophysiology of these ocular adverse events.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Ophthalmology

Keratoconus Prevalence in Families: A French Study

Gabrielle Lapeyre, Pierre Fournie, Raphael Vernet, Stephanie Roseng, Francois Malecaze, Emmanuelle Bouzigon, David Touboul

CORNEA (2020)

Article Ophthalmology

Transepithelial Corneal Cross-Linking With Supplemental Oxygen in Keratoconus: 1-Year Clinical Results

Alex Matthys, Myriam Cassagne, Stephane D. Galiacy, Safa El Hout, Pierre Fournie, Francois Malecaze

Summary: Transepithelial CXL performed in an oxygen-rich atmosphere results in improved Kmax and CDVA with good safety. The most frequent adverse event was corneal haze.

JOURNAL OF REFRACTIVE SURGERY (2021)

Article Multidisciplinary Sciences

Use of the heads-up NGENUITY 3D Visualization System for vitreoretinal surgery: a retrospective evaluation of outcomes in a French tertiary center

Pierre Kantor, Frederic Matonti, Fanny Varenne, Vanessa Sentis, Veronique Pagot-Mathis, Pierre Fournie, Vincent Soler

Summary: The study compared the effectiveness and safety of conventional microscopy and the NGENUITY 3D Visualization System in vitreoretinal surgeries, finding no significant differences in postoperative rates of RD recurrence, MH closure, or decrease in ERM central macular thickness between the two groups. Surgery durations and visual prognosis were also similar. The NGENUITY System shows promise for integration into future robotized interventions.

SCIENTIFIC REPORTS (2021)

Article Ophthalmology

New polynomial regression formula to improve second-eye refractive outcomes in sequential bilateral cataract surgery

Edouard Klein, Francois Malecaze, Victor Bart, Anouk Barnoud, Pierre Levy, Laurent Gauthier, Pierre Fournie

Summary: This study aimed to improve the calculation of intraocular lens power for the second eye in cataract surgery. A new polynomial regression formula (WO2nd) was developed and compared with other formulas. The results showed that WO2nd performed well in predicting refractive errors and was particularly effective for eyes with shorter axial length.

JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2022)

Review Allergy

Ocular complications induced during dupilumab treatment of atopic dermatitis

M. Cassagne, S. Galiacy, M. Tauber, C. Paul, P. Fournie, M. Simon

Summary: Atopic dermatitis is a common chronic inflammatory skin disease with multifactorial etiology. Dupilumab, the first approved biomolecule for moderate to severe AD, has shown effectiveness but may cause adverse eye events that require careful management. Understanding molecular mechanisms is key for identifying at-risk patients and optimizing treatment in collaboration between dermatologists and ophthalmologists.

REVUE FRANCAISE D ALLERGOLOGIE (2021)

Editorial Material Ophthalmology

Stars in their eyes

F. Varenne, J. Pereira Lopes, C. Escudier, P. Kantor, M. Cassagne, V Soler, P. Fournie

JOURNAL FRANCAIS D OPHTALMOLOGIE (2022)

Article Ophthalmology

Dupilumab-related blepharoconjunctivitis: Recommendations of the CEDRE group. Atopic dermatitis, conjunctivitis and dupilumab: Which management approach?

S. Doan, L. Arnould, C. Febvay, P. Fournie, J. Gueudry, P. Labalette, C. Ouilhon, T-H-C Tran, B. Vabres, S. Barbarot, J-D Bouaziz, A. Du-Thanh, M. Jachiet, J. Seneschal, A. Soria, D. Staumont-Salle, C. Baudouin, B. Mortemousque

Summary: Dupilumab is a monoclonal antibody that inhibits IL4 and IL13 signaling and is used to treat moderate to severe atopic dermatitis. It has been associated with conjunctivitis and blepharoconjunctivitis as side effects, with a higher incidence observed in patients with atopic dermatitis compared to placebo. However, there are currently no official joint recommendations for the prevention and management of conjunctivitis in patients using dupilumab. Further research and guidance are needed.

JOURNAL FRANCAIS D OPHTALMOLOGIE (2022)

Article Medicine, General & Internal

Ocular Inflammation Induced by Immune Checkpoint Inhibitors

Florence Chaudot, Pascal Seve, Antoine Rousseau, Alexandre Thibault Jacques Maria, Pierre Fournie, Pierre Lozach, Jeremy Keraen, Marion Servant, Romain Muller, Baptiste Gramont, Sara Touhami, Habeeb Mahmoud, Pierre-Antoine Quintart, Stephane Dalle, Olivier Lambotte, Laurent Kodjikian, Yvan Jamilloux

Summary: This study analyzed ocular immunotherapy-related adverse events (IRAEs) diagnosed in France after the marketing of immune checkpoint inhibitors (ICPIs). The results showed that these events were more common in patients undergoing treatment for metastatic melanoma, and local or systemic corticosteroids were effective in controlling them.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Ophthalmology

First-line management of necrotizing herpetic retinitis by prioritizing the investigation of immune status and prognostic factors for poor visual outcomes

Emmanuelle Loubsens, Raphael Adam, Alexa Debard, Lisa Barioulet, Fanny Varenne, Pierre Fournie, Thomas Sales de Gauzy, Priscille Olle, Guillaume Martin-Blondel, Vincent Soler

Summary: This study reviewed the management, treatment, and outcomes of patients with necrotizing herpetic retinitis (NHR) and proposed an algorithm for first-line management of NHR. The visual prognosis of NHR patients was poor and prompt investigation of immune status and presence of factors justifying intravitreal antiviral injections is necessary.

INTERNATIONAL OPHTHALMOLOGY (2023)

Article Multidisciplinary Sciences

Corneal epithelium in keratoconus underexpresses active NRF2 and a subset of oxidative stress-related genes

Tatiana Lupasco, Zhiguo He, Myriam Cassagne, Tomy Sagnial, Lise Brion, Pierre Fournie, Philippe Gain, Gilles Thuret, Michele Allouche, Francois Malecaze, Michel Simon, Stephane D. Galiacy

Summary: The study found that there is a downregulation of gene expression related to mechanical resistance and oxidative stress pathways in early keratoconus samples. Expression of SPRR2A and HMOX1 is also reduced in advanced keratoconus samples. Additionally, there is a decreased expression of KRT16 and KRT14 proteins, as well as differential localization of involucrin protein. Furthermore, immunofluorescence staining for the active form of NRF2 is reduced in keratoconus epithelia compared to controls.

PLOS ONE (2022)

Article Allergy

Dupilumab-Associated Adverse Events During Treatment of Allergic Diseases

Anna Kychygina, Myriam Cassagne, Marie Tauber, Stephane Galiacy, Carle Paul, Pierre Fournie, Michel Simon

Summary: Dupilumab is a new biological therapy for atopic diseases, which has shown effectiveness in treating atopic dermatitis, asthma, and chronic rhinosinusitis. However, it is associated with various adverse events including injection-site reactions, ophthalmic complications, dermatitis, psoriatic lesions, lymphoma exacerbation, alopecia areata, hypereosinophilia, and arthritis. The molecular origin of these adverse events is unclear and further research is needed.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2022)

No Data Available